Neurocrine Biosciences Inc

NBIX · Moat type: REGULIERUNG

MoatScore

6/10

Fair Value

53 USD

Margin of Safety

-228.5 %

Rating

BEOBACHTEN

GESCHÄFTSMODELL Neurocrine Biosciences develops and markets specialty pharmaceuticals in the fields of neurology and neuroendocrinology – revenue is generated primarily through prescription products with patent protection, supplemented by licensing agreements and milestone payments from partnership contracts.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.